SEC Comment Letter 0000000000-24-012382 to Autolus Therapeutics plc (AUTL)

Autolus Therapeutics plc
Date: Nov. 7, 2024 · CIK: 0001730463 · Accession: 0000000000-24-012382

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-38547

Date

November 7, 2024

Author

Christian Itin, Ph.D.

Form

UPLOAD

Company

Autolus Therapeutics plc

Letter

November 7, 2024 Christian Itin, Ph.D. Chief Executive Officer Autolus Therapeutics plc 191 Wood Lane London W12 7FP United Kingdom Re:Autolus Therapeutics plc Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-38547 Dear Christian Itin Ph.D.: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

November 7, 2024
Christian Itin, Ph.D.
Chief Executive Officer
Autolus Therapeutics plc
191 Wood Lane
London W12 7FP
United Kingdom
Re:Autolus Therapeutics plc
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-38547
Dear Christian Itin Ph.D.:
            We have completed our review of your filing. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io